Follow
Sharad Darandale
Sharad Darandale
Deputy Manager, IQGEN-X Pharma Pvt. Ltd.
Verified email at iqgenx.com
Title
Cited by
Cited by
Year
Cyclodextrin-based nanosponges: effective nanocarrier for Tamoxifen delivery
S Torne, S Darandale, P Vavia, F Trotta, R Cavalli
Pharmaceutical development and technology 18 (3), 619-625, 2013
1712013
Cyclodextrin-based nanosponges of curcumin: formulation and physicochemical characterization
SS Darandale, PR Vavia
Journal of inclusion phenomena and macrocyclic chemistry 75, 315-322, 2013
1632013
Niosomes as a vesicular carrier for topical administration of minoxidil: formulation and in vitro assessment
N Mali, S Darandale, P Vavia
Drug delivery and translational research 3, 587-592, 2013
842013
Design of a gastroretentive mucoadhesive dosage form of furosemide for controlled release
SS Darandale, PR Vavia
Acta Pharmaceutica Sinica B 2 (5), 509-517, 2012
732012
Drug delivery| bioavailability-nanosponge-aided drug delivery: a closer look
S Swaminathan, S Darandale, PR Vavia
Pharm Formul Qual 14 (5), 12-5, 2012
222012
Effect of lipid composition in propofol formulations: decisive component in reducing the free propofol content and improving pharmacodynamic profiles
SS Darandale, GB Shevalkar, PR Vavia
Aaps Pharmscitech 18, 441-450, 2017
112017
Fabrication and statistical optimization of a polysaccharide-based sublingual film of buprenorphine hydrochloride for breakthrough pain management: in vitro and in vivo performance
GS Yeola, S Darandale, A Khire, PR Vavia
Drug delivery and translational research 4, 116-125, 2014
72014
DOI: Fund: Corresponding Authors: About author
SS Darandale, PR Vavia
The system can't perform the operation now. Try again later.
Articles 1–8